These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33962361)

  • 1. School performance and behavioral functioning in children after intrauterine transfusions for hemolytic disease of the fetus and newborn.
    Ree IMC; van 't Oever RM; Jansen L; Lopriore E; de Haas M; van Klink JMM
    Early Hum Dev; 2021 Jun; 157():105381. PubMed ID: 33962361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: A nationwide retrospective cohort study.
    Van't Oever RM; Zwiers C; de Haas M; le Cessie S; Lopriore E; Oepkes D; Verweij EJTJ
    BJOG; 2024 May; 131(6):769-776. PubMed ID: 37743689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.
    Verduin EP; Lindenburg IT; Smits-Wintjens VE; van Klink JM; Schonewille H; van Kamp IL; Oepkes D; Walther FJ; Kanhai HH; Doxiadis II; Lopriore E; Brand A
    BMC Pregnancy Childbirth; 2010 Dec; 10():77. PubMed ID: 21122095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D; Lopriore E
    BMC Pregnancy Childbirth; 2023 Oct; 23(1):738. PubMed ID: 37853331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?
    Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E
    Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and Treatment Outcomes of Hemolytic Disease of the Fetus and Newborn (HDFN)-A Retrospective Cohort Study.
    Drozdowska-Szymczak A; Łukawska S; Mazanowska N; Ludwin A; Krajewski P
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39200927
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn.
    McCarthy WA; Popek EJ
    Pediatr Dev Pathol; 2017; 20(6):469-474. PubMed ID: 29187036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
    Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
    Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
    Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
    J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions.
    Strindberg J; Lundahl J; Ajne G
    Immunohematology; 2013; 29(2):51-4. PubMed ID: 24094236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn.
    Trevett TN; Dorman K; Lamvu G; Moise KJ
    Am J Obstet Gynecol; 2005 Feb; 192(2):478-82. PubMed ID: 15695990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of Hemolytic Disease of the Fetus and Newborn Treated Without Blood Products.
    Hirschman L; Munchel A
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):e118-e120. PubMed ID: 38032187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.